These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7372794

  • 1. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
    Quigley ME, Judd SJ, Gilliland GB, Yen SS.
    J Clin Endocrinol Metab; 1980 Jun; 50(6):994-8. PubMed ID: 7372794
    [No Abstract] [Full Text] [Related]

  • 2. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME, Judd SJ, Gilliland GB, Yen SS.
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [Abstract] [Full Text] [Related]

  • 3. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O, Beauregard H, Somma M, Comtois R, Jilwan N, Hardy J.
    Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
    [Abstract] [Full Text] [Related]

  • 4. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
    Seki K, Kato K, Shima K.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
    [Abstract] [Full Text] [Related]

  • 5. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A, De Marinis L, Maira G, Menini E, Anile C.
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [Abstract] [Full Text] [Related]

  • 6. [Kinetics of prolactinemia after withdrawal of dopamine perfusion and during the administration of domperidone. Normal and hyperprolactinemic subjects (prolactinomas and suprahypophyseal lesions)].
    Bercovici JP, Khoury S, Tater D, Besson G, Caroff J.
    Biomed Pharmacother; 1983 Nov; 37(5):222-7. PubMed ID: 6661508
    [Abstract] [Full Text] [Related]

  • 7. Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
    Seki K, Uesato T, Kato K, Shima K.
    Endocrinol Jpn; 1984 Dec; 31(6):733-9. PubMed ID: 6532792
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects.
    Serri O, Kuchel O, Buu NT, Somma M.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):255-9. PubMed ID: 6822635
    [Abstract] [Full Text] [Related]

  • 9. Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma.
    Quigley ME, Yen SS.
    Am J Obstet Gynecol; 1980 Jul 15; 137(6):653-5. PubMed ID: 7395929
    [Abstract] [Full Text] [Related]

  • 10. Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 Mar 15; 50(3):427-30. PubMed ID: 7358828
    [Abstract] [Full Text] [Related]

  • 11. Metoclopramide challenge: a measure of human lactotroph activity.
    Martin RH.
    Obstet Gynecol; 1983 Dec 15; 62(6):691-5. PubMed ID: 6633994
    [Abstract] [Full Text] [Related]

  • 12. Prolactin-secreting adenomas in women. VII. Dopamine regulation of prolactin secretion.
    Martin MC, Weiner RI, Monroe SE, Roberts JM, Licko V, Jaffe RB.
    J Clin Endocrinol Metab; 1984 Sep 15; 59(3):485-90. PubMed ID: 6746862
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Progress in the hormonal detection of pituitary prolactin adenoma].
    De Gennes JL, Turpin G, Heshmati HM, Carayon A.
    Ann Med Interne (Paris); 1982 Sep 15; 133(1):12-6. PubMed ID: 7065584
    [No Abstract] [Full Text] [Related]

  • 15. Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
    Gonzalez-Villapando C, Szabo M, Frohman LA.
    J Clin Endocrinol Metab; 1980 Dec 15; 51(6):1417-24. PubMed ID: 7440704
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G, Chernova T, Goncharov N.
    Acta Med Austriaca; 1992 Dec 15; 19 Suppl 1():86-8. PubMed ID: 1519463
    [Abstract] [Full Text] [Related]

  • 18. Prolactin response to perphenazine. A sensitive and specific test for pituitary tumor in hyperprolactinemic women.
    Mattox JH, Fortunato SJ.
    J Reprod Med; 1986 Dec 15; 31(12):1098-101. PubMed ID: 3795197
    [Abstract] [Full Text] [Related]

  • 19. [Normalization of the prolactin values during alfa-interferon therapy: the considerations with a female patient with anti-HCV-positive chronic hepatitis and prolactin-secreting hypophyseal microadenoma].
    Zennaro R, Petracca EG, Paolini R, Ramazzina E.
    Clin Ter; 1996 Apr 15; 147(4):169-71. PubMed ID: 8766348
    [Abstract] [Full Text] [Related]

  • 20. Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma.
    Seki K, Kato K, Shima K.
    J Clin Endocrinol Metab; 1986 Apr 15; 62(4):783-4. PubMed ID: 3512593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.